Cannell & Spears’s Elevance Health ELV Stock Holding History

Cannell & Spears’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.9M	Buy	23,570 +8,897	+61%	+$2.92M	0.14%	113
2025 Q4	$5.14M	Sell	14,673 -594	-4%	-$201K	0.1%	133
2025 Q3	$4.93M	Sell	15,267 -11,137	-42%	-$3.46M	0.09%	145
2025 Q2	$10.3M	Buy	26,404 +176	+0.7%	+$70.8K	0.21%	98
2025 Q1	$11.4M	Sell	26,228 -2,194	-8%	-$881K	0.25%	91
2024 Q4	$10.5M	Sell	28,422 -37,810	-57%	-$15.8M	0.22%	98
2024 Q3	$34.4M	Sell	66,232 -571	-0.9%	-$305K	0.68%	51
2024 Q2	$36.2M	Buy	66,803 +121	+0.2%	+$64K	0.75%	43
2024 Q1	$34.6M	Buy	66,682 +1,995	+3%	+$992K	0.71%	45
2023 Q4	$30.5M	Buy	64,687 +182	+0.3%	+$84.2K	2.43%	15
2023 Q3	$28.1M	Buy	64,505 +49	+0.1%	+$22.2K	2.41%	16
2023 Q2	$28.6M	Buy	64,456 +59,858	+1,302%	+$27.6M	2.34%	15
2023 Q1	$2.11M	Buy	+4,598	New	+$2.19M	0.19%	60

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Cannell & Spears's ELV Position: Q1 2026 in Review

Cannell & Spears increased its Elevance Health (ELV) stake by 61% in Q1 2026, buying an estimated $2.92M and bringing the position to 23,570 shares worth $6.9M. The position accounts for 0.14% of the portfolio, ranked #113.

Cannell & Spears first reported a position in ELV in Q1 2023 and has held it in 13 quarters since. The position peaked at $36.2M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Cannell & Spears held 23,570 shares of Elevance Health worth $6.9M as of Q1 2026.
Cannell & Spears bought 8,897 Elevance Health shares in Q1 2026, an estimated $2.92M.
Elevance Health made up 0.14% of Cannell & Spears's portfolio in Q1 2026, its #113 holding.
Cannell & Spears first reported a position in Elevance Health in Q1 2023 and has held it in 13 quarters since.
Cannell & Spears's Elevance Health position peaked at $36.2M in Q2 2024.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.